Objective: To evaluate the accuracy of high-spatial resolution T2-weighted endorectal magnetic resonance imaging (eMRI) for detection and pattern depiction of seminal vesicle invasion (SVI) in patients with prostate cancer (PCa). Methods: 376 patients were included who underwent eMRI for staging before radical open prostatectomy at 1.5 T with an endorectal coil. Statistical accuracy for detection of SVI was calculated. MR images of patients with SVI were further evaluated by two radiologists according to the classification by Wheeler and Ohori. Results: In the cohort, 35 patients had SVI after histopathological evaluation of the prostatectomy specimen (stage pT3b). Sensitivity and specificity for detection of SVI were 48.6 and 97.7%, respectively. Negative and positive predictive values and overall accuracy were 94.9, 68.0, and 93.1%, respectively. Infiltration pattern analysis showed that type I invasion was most common with 48.6 followed by type IIa (31.4%) and IIb (20%). Type III was not present. There was no statistical significant difference between the three groups regarding Gleason score, age, and prostate-specific antigen level. Conclusions: eMRI with high-spatial resolution T2-weighted imaging is accurate for assessment of SVI. Depiction of different infiltration types of SVI is feasible. By adding information about the extent of SVI, diagnostic reporting and risk stratification could be improved.

Keywords:
Accuracy, Endorectal coil, MR imaging, Infiltration-type analysis, Prostate cancer, Seminal vesicle invasion
1.
Pierorazio PM, Ross AE, Schaeffer EM, Epstein JI, Han M, Walsh PC, Partin AW: A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy. J Urol 2011;185:1691-1697.
2.
Sala E, Akin O, Moskowitz CS, Eisenberg HF, Kuroiwa K, Ishill NM, Rajashanker B, Scardino PT, Hricak H: Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis. Radiology 2006;238:929-937.
3.
Wang L, Hricak H, Kattan MW, Chen HN, Kuroiwa K, Eisenberg HF, Scardino PT: Prediction of seminal vesicle invasion in prostate cancer: Incremental value of adding endorectal MR imaging to the Kattan nomogram. Radiology 2007;242:182-188.
4.
Futterer JJ, Yakar D, Strijk SP, Barentsz JO: Preoperative 3T MR imaging of rectal cancer: local staging accuracy using a two-dimensional and three-dimensional T2-weighted turbo spin echo sequence. Eur J Radiol 2008;65:66-71.
5.
Futterer JJ, Engelbrecht MR, Jager GJ, Hartman RP, King BF, Hulsbergen-Van de Kaa CA, Witjes JA, Barentsz JO: Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils. Local staging accuracy of prostate cancer using endorectal coil MR imaging. Eur Radiol 2007;17:1055-1065.
6.
Perrotti M, Kaufman RP Jr, Jennings TA, Thaler HT, Soloway SM, Rifkin MD, Fisher HA: Endorectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate? J Urol 1996;156:106-109.
7.
Zhang JQ, Loughlin KR, Zou KH, Haker S, Tempany CM: Role of endorectal coil magnetic resonance imaging in treatment of patients with prostate cancer and in determining radical prostatectomy surgical margin status: report of a single surgeon's practice. Urology 2007;69:1134-1137.
8.
Rorvik J, Halvorsen OJ, Albrektsen G, Ersland L, Daehlinl L, Haukaas S: MRI with an endorectal coil for staging of clinically localised prostate cancer prior to radical prostatectomy. Eur Radiol 1999;9:29-34.
9.
Jewett HJ, Eggleston JC, Yawn DH: Radical prostatectomy in the management of carcinoma of the prostate: probable causes of some therapeutic failures. J Urol 1972;107:1034-1040.
10.
Ohori M, Scardino PT, Lapin SL, Seale-Hawkins C, Link J, Wheeler TM: The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer. Am J Surg Pathol 1993;17:1252-1261.
11.
Villers AA, McNeal JE, Redwine EA, Freiha FS, Stamey TA: Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma. J Urol 1990;143:1183-1187.
12.
McNeal JE, Yemoto CE: Significance of demonstrable vascular space invasion for the progression of prostatic adenocarcinoma. Am J Surg Pathol 1996;20:1351-1360.
13.
Debras B, Guillonneau B, Bougaran J, Chambon E, Vallancien G: Prognostic significance of seminal vesicle invasion on the radical prostatectomy specimen. Rationale for seminal vesicle biopsies. Eur Urol 1998;33:271-277.
14.
Epstein JI, Partin AW, Potter SR, Walsh PC: Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters. Urology 2000;56:283-288.
15.
Potter SR, Epstein JI, Partin AW: Seminal vesicle invasion by prostate cancer: prognostic significance and therapeutic implications. Rev Urol 2000;2:190-195.
16.
Wheeler TM: Anatomic considerations in carcinoma of the prostate. Urol Clin North Am 1989;16:623-634.
17.
D'Amico AV, Schnall M, Whittington R, Malkowicz SB, Schultz D, Tomaszewski JE, Wein A: Endorectal coil magnetic resonance imaging identifies locally advanced prostate cancer in select patients with clinically localized disease. Urology 1998;51:449-454.
18.
D'Amico AV, Whittington R, Malkowicz SB, Schnall M, Tomaszewski J, Schultz D, Kao G, VanArsdalen K, Wein A: A multivariable analysis of clinical factors predicting for pathological features associated with local failure after radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys 1994;30:293-302.
19.
Brajtbord JS, Lavery HJ, Nabizada-Pace F, Senaratne P, Samadi DB: Endorectal magnetic resonance imaging has limited clinical ability to preoperatively predict pt3 prostate cancer. BJU Int 2011;107:1419-1424.
20.
Nakashima J, Tanimoto A, Imai Y, Mukai M, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T, Marumo K, Murai M: Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. Urology 2004;64:101-105.
21.
Nepple KG, Rosevear HM, Stolpen AH, Brown JA, Williams RD: Concordance of preoperative prostate endorectal MRI with subsequent prostatectomy specimen in high-risk prostate cancer patients. Urol Oncol 2011 (E-pub ahead of print).
22.
Porcaro AB, Borsato A, Romano M, Sava T, Ghimenton C, Migliorini F, Monaco C, Rubilotta E, Antoniolli SZ, Lacola V, Montemezzi S: Accuracy of preoperative endorectal coil magnetic resonance imaging in detecting clinical understaging of localized prostate cancer. World J Urol 2012 (E-pub ahead of print).
23.
Turkbey B, Pinto PA, Mani H, Bernardo M, Pang Y, McKinney YL, Khurana K, Ravizzini GC, Albert PS, Merino MJ, Choyke PL: Prostate cancer: Value of multiparametric MR imaging at 3 T for detection - histopathologic correlation. Radiology 2010;255:89-99.
24.
Franiel T: Multiparametric magnetic resonance imaging of the prostate - technique and clinical applications (in German). Rofo 2011;183:607-617.
25.
Rothke M, Blondin D, Schlemmer HP, Franiel T: PI-RADS classification: Structured reporting for MRI of the prostate (in German). Rofo 2013;185:253-261.
26.
Schlemmer HP: Multiparametric MRI of the prostate: method for early detection of prostate cancer? (in German) Rofo 2010;182:1067-1075.
27.
Hoeks CM, Barentsz JO, Hambrock T, Yakar D, Somford DM, Heijmink SW, Scheenen TW, Vos PC, Huisman H, van Oort IM, Witjes JA, Heerschap A, Futterer JJ: Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 2011;261:46-66.
28.
Soylu FN, Peng Y, Jiang Y, Wang S, Schmid-Tannwald C, Sethi I, Eggener S, Antic T, Oto A: Seminal vesicle invasion in prostate cancer: evaluation by using multiparametric endorectal MR imaging. Radiology 2013;267:797-806.
29.
Jung DC, Lee HJ, Kim SH, Choe GY, Lee SE: Preoperative MR imaging in the evaluation of seminal vesicle invasion in prostate cancer: pattern analysis of seminal vesicle lesions. J Magn Reson Imaging 2008;28:144-150.
30.
Kim CK, Choi D, Park BK, Kwon GY, Lim HK: Diffusion-weighted MR imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial results. J Magn Reson Imaging 2008;28:963-969.
31.
McNeal JE, Yemoto CE: Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations. Am J Surg Pathol 1996;20:802-814.
32.
Koh H, Kattan MW, Scardino PT, Suyama K, Maru N, Slawin K, Wheeler TM, Ohori M: A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results. J Urol 2003;170:1203-1208.
33.
Ohori M, Wheeler TM, Kattan MW, Goto Y, Scardino PT: Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 1995;154:1818-1824.
34.
Rouse P, Shaw G, Ahmed HU, Freeman A, Allen C, Emberton M: Multi-parametric magnetic resonance imaging to rule-in and rule-out clinically important prostate cancer in men at risk: a cohort study. Urol Int 2011;87:49-53.
35.
Colleselli D, Schilling D, Lichy MP, Hennenlotter J, Vogel UH, Krueger SA, Kuehs U, Schlemmer HP, Stenzl A, Schwentner C: Topographical sensitivity and specificity of endorectal coil magnetic resonance imaging for prostate cancer detection. Urol Int 2010;84:388-394.
36.
Goris Gbenou MC, Peltier A, Addla SK, Lemort M, Bollens R, Larsimont D, Roumeguere T, Schulman CC, van Velthoven R: Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy. Urol Int 2012;88:12-17.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.